Publicaciones (101) Publicaciones de DIEGO RINCÓN RODRÍGUEZ

2024

  1. At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods

    Scientific Reports, Vol. 14, Núm. 1

  2. Demographic Trends in Liver Transplant Survivors after 3 Decades of Program Implementation: The Impact of Cohort and Period Effects on Life Expectancy

    Transplantation Direct, Vol. 10, Núm. 8, pp. e1684

  3. Hepatic hemodynamic study: More than just HVPG measurement

    Gastroenterologia y Hepatologia

  4. Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure

    Hepatology

  5. Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure

    Journal of Hepatology, Vol. 81, Núm. 1, pp. 76-83

  6. Stroke in critically ill patients with respiratory failure due to COVID-19: Disparities between low-middle and high-income countries

    Heart and Lung, Vol. 68, pp. 131-144

  7. Total Neoadjuvant Therapy Approach for the Treatment of Locally Advanced Rectal Cancer: Where Do We Stand?

    Oncology (Switzerland), Vol. 102, Núm. 7, pp. 646-657

2023

  1. CT-derived liver and spleen volume accurately diagnose clinically significant portal hypertension in patients with hepatocellular carcinoma

    JHEP Reports, Vol. 5, Núm. 3

  2. Liver injury in hospitalized patients with COVID-19: An International observational cohort study

    PLoS ONE, Vol. 18, Núm. 9 September

  3. Portal hypertension increases the risk of hepatic decompensation after 90Yttrium radioembolization in patients with hepatocellular carcinoma: a cohort study

    Therapeutic Advances in Gastroenterology, Vol. 16

  4. Prognostic implications of systolic function in patients with cirrhosis

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 6, pp. 446-454

  5. Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry

    Research and Practice in Thrombosis and Haemostasis, Vol. 7, Núm. 5

2022

  1. Correction to: The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study

    The American journal of gastroenterology, Vol. 117, Núm. 5, pp. 818

  2. Hepatitis C eradication improves cognitive function in patients with or without cirrhosis: A prospective real-life study

    European Journal of Neurology, Vol. 29, Núm. 2, pp. 400-412

  3. Liver and spleen volumes are associated with prognosis of compensated and decompensated cirrhosis and parallel its natural history

    United European Gastroenterology Journal, Vol. 10, Núm. 8, pp. 805-816

  4. Non-pharmacologic direct cost of a simplified strategy with glecaprevir/pibrentasvir for 8 weeks in naïve non-cirrhotic patients with hepatitis C implemented in clinical practice. The Just SIMPLE Study

    Gastroenterologia y Hepatologia, Vol. 45, Núm. 5, pp. 342-349

  5. The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study

    American Journal of Gastroenterology, Vol. 117, Núm. 2, pp. 301-310

2021

  1. An appraisal of respiratory system compliance in mechanically ventilated covid-19 patients

    Critical Care, Vol. 25, Núm. 1

  2. HCV eradication in recurrent hepatitis C after liver transplantation normalizes enhanced endothelial activation

    Transplant International, Vol. 34, Núm. 11, pp. 2214-2225

  3. Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study

    Journal of Hepatology, Vol. 75, Núm. 5, pp. 1026-1033